NASDAQ:HZNP - Nasdaq - IE00BQPVQZ61 - Common Stock - Currency: USD
Overall HZNP gets a fundamental rating of 6 out of 10. We evaluated HZNP against 560 industry peers in the Biotechnology industry. HZNP has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. HZNP has a decent growth rate and is not valued too expensively. These ratings would make HZNP suitable for quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 4.71% | ||
ROE | 8.25% | ||
ROIC | 5.35% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 15.58% | ||
PM (TTM) | 12.02% | ||
GM | 75.21% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.48 | ||
Debt/FCF | 2.67 | ||
Altman-Z | 5.1 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.27 | ||
Quick Ratio | 4.09 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 25.9 | ||
Fwd PE | 20.14 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 27.79 | ||
EV/EBITDA | 27.94 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
116.3
+0.05 (+0.04%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 25.9 | ||
Fwd PE | 20.14 | ||
P/S | 7.31 | ||
P/FCF | 27.79 | ||
P/OCF | 25.59 | ||
P/B | 5.01 | ||
P/tB | 26.53 | ||
EV/EBITDA | 27.94 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 4.71% | ||
ROE | 8.25% | ||
ROCE | 6.77% | ||
ROIC | 5.35% | ||
ROICexc | 7.58% | ||
ROICexgc | 27.86% | ||
OM | 15.58% | ||
PM (TTM) | 12.02% | ||
GM | 75.21% | ||
FCFM | 26.3% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.48 | ||
Debt/FCF | 2.67 | ||
Debt/EBITDA | 2.66 | ||
Cap/Depr | 21.15% | ||
Cap/Sales | 2.26% | ||
Interest Coverage | 4.07 | ||
Cash Conversion | 108.78% | ||
Profit Quality | 218.81% | ||
Current Ratio | 4.27 | ||
Quick Ratio | 4.09 | ||
Altman-Z | 5.1 |